FCGR2B and glioblastoma: In the other single-cell RNA-seq analysis using the Brain Immune Atlas, we found that FCGR2B was almost expressed in tumor-associated macrophages (TAMs) and dendritic cells (DCs) and was expressed at higher levels in recurrent GBM samples than in newly diagnosed samples (Figures 5C, D).